FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Noven Pharmaceuticals Daytrana Recall

Daytrana (methylphenidate transdermal system), Delivers 10 mg over 9 hours (1

Noven Pharmaceuticals Inc · Miami, FL

Risk level
Class II
Reported by FDA
Jun 2, 2021
Recall ID
D-0393-2021
Check your lot numberHow we source this data

Summary

Noven Pharmaceuticals recalled Daytrana starting May 20, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0393-2021 on Jun 2, 2021. Reason: Defective Delivery System: The number of customer complaints for ripping patches and tight release/adhesive transfer have exceeded the action limits. Status: Ongoing.

Why it was recalled

Defective Delivery System: The number of customer complaints for ripping patches and tight release/adhesive transfer have exceeded the action limits.

Product description

Daytrana (methylphenidate transdermal system), Delivers 10 mg over 9 hours (1.1 mg/hr), 30 Patches (NDC 68968-5552-1) per box (NDC 68968-5552-3), Rx only, Manufactured for Noven Therapeutics, LLC., Miami, FL 33186; By Noven Pharmaceuticals, Inc., Miami, FL 33186.

Lot numbers, UPCs & expiration codes

Lot: 88528 Exp. 09/2021

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0393-2021
Classification
Class II
Status
Ongoing
Recall initiated
May 20, 2021
FDA report date
Jun 2, 2021
Quantity
9,587 boxes
Recall type
Voluntary: Firm initiated
Recalling firm
Noven Pharmaceuticals Inc

Original FDA data

Every field from FDA enforcement report D-0393-2021, exactly as published.

Show all FDA fields
City
Miami
State
FL
Status
Ongoing
Country
United States
Event ID
87980
Address
11960 Sw 144th St
Code information
Lot: 88528 Exp. 09/2021
Postal code
33186-6109
Report date
Jun 2, 2021
Product type
Drugs
Recall number
D-0393-2021
Classification
Class II
Recalling firm
Noven Pharmaceuticals Inc
Product quantity
9,587 boxes
Reason for recall
Defective Delivery System: The number of customer complaints for ripping patches and tight release/adhesive transfer have exceeded the action limits.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Daytrana (methylphenidate transdermal system), Delivers 10 mg over 9 hours (1.1 mg/hr), 30 Patches (NDC 68968-5552-1) per box (NDC 68968-5552-3), Rx only, Manufactured for Noven Therapeutics, LLC., Miami, FL 33186; By Noven Pharmaceuticals, Inc., Miami, FL 33186.
Distribution pattern
Nationwide in the USA
Recall initiation date
May 20, 2021
Initial firm notification
Letter
Center classification date
May 24, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0393-2021, published Jun 2, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls